Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor

Tschesche H, BLÄSER J, KLEINE T, SCHNIERER S, REINEMER P, BODE W, MAASJOSHUSMANN U, FRICKE C (1994)
In: Inhibition of Matrix Metalloproteinases: Therapeutic Potential. Annals of the New York Academy of Sciences, 732(1). New York Acad. of Sciences: 400-402.

Konferenzbeitrag | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Tschesche, HaraldUniBi; BLÄSER, J.; KLEINE, T.; SCHNIERER, S.; REINEMER, P.; BODE, W.; MAASJOSHUSMANN, U.; FRICKE, C.
Einrichtung
Fakultät für Chemie > Biochemie I
Erscheinungsjahr
1994
Titel des Konferenzbandes
Inhibition of Matrix Metalloproteinases: Therapeutic Potential
Serien- oder Zeitschriftentitel
Annals of the New York Academy of Sciences
Band
732
Ausgabe
1
Seite(n)
400-402
ISSN
0077-8923
Page URI
https://pub.uni-bielefeld.de/record/1640736

Zitieren

Tschesche H, BLÄSER J, KLEINE T, et al. Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor. In: Inhibition of Matrix Metalloproteinases: Therapeutic Potential. Annals of the New York Academy of Sciences. Vol 732. New York Acad. of Sciences; 1994: 400-402.
Tschesche, H., BLÄSER, J., KLEINE, T., SCHNIERER, S., REINEMER, P., BODE, W., MAASJOSHUSMANN, U., et al. (1994). Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor. Inhibition of Matrix Metalloproteinases: Therapeutic Potential, Annals of the New York Academy of Sciences, 732, 400-402. New York Acad. of Sciences. https://doi.org/10.1111/j.1749-6632.1994.tb24766.x
Tschesche, Harald, BLÄSER, J., KLEINE, T., SCHNIERER, S., REINEMER, P., BODE, W., MAASJOSHUSMANN, U., and FRICKE, C. 1994. “Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor”. In Inhibition of Matrix Metalloproteinases: Therapeutic Potential, 732:400-402. Annals of the New York Academy of Sciences. New York Acad. of Sciences.
Tschesche, H., BLÄSER, J., KLEINE, T., SCHNIERER, S., REINEMER, P., BODE, W., MAASJOSHUSMANN, U., and FRICKE, C. (1994). “Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor” in Inhibition of Matrix Metalloproteinases: Therapeutic Potential Annals of the New York Academy of Sciences, vol. 732, (New York Acad. of Sciences), 400-402.
Tschesche, H., et al., 1994. Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor. In Inhibition of Matrix Metalloproteinases: Therapeutic Potential. Annals of the New York Academy of Sciences. no.732 New York Acad. of Sciences, pp. 400-402.
H. Tschesche, et al., “Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor”, Inhibition of Matrix Metalloproteinases: Therapeutic Potential, Annals of the New York Academy of Sciences, vol. 732, New York Acad. of Sciences, 1994, pp.400-402.
Tschesche, H., BLÄSER, J., KLEINE, T., SCHNIERER, S., REINEMER, P., BODE, W., MAASJOSHUSMANN, U., FRICKE, C.: Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor. Inhibition of Matrix Metalloproteinases: Therapeutic Potential. Annals of the New York Academy of Sciences. 732, p. 400-402. New York Acad. of Sciences (1994).
Tschesche, Harald, BLÄSER, J., KLEINE, T., SCHNIERER, S., REINEMER, P., BODE, W., MAASJOSHUSMANN, U., and FRICKE, C. “Inhibition of Matrix Metalloproteinases in Rheumatoid Arthritis and the Crystallographic Binding Mode of a Peptide Inhibitor”. Inhibition of Matrix Metalloproteinases: Therapeutic Potential. New York Acad. of Sciences, 1994.Vol. 732. Annals of the New York Academy of Sciences. 400-402.

4 References

Daten bereitgestellt von Europe PubMed Central.

Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.
Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H., J. Clin. Chem. Clin. Biochem. 27(6), 1989
PMID: 2547014
The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
Schnierer S, Kleine T, Gote T, Hillemann A, Knauper V, Tschesche H., Biochem. Biophys. Res. Commun. 191(2), 1993
PMID: 8460992
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H., EMBO J. 13(6), 1994
PMID: 8137810
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.
Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W., FEBS Lett. 338(2), 1994
PMID: 8307185
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 7978819
PubMed | Europe PMC

Suchen in

Google Scholar